Ureteroscopic management of upper tract urothelial carcinoma ( <scp>UTUC</scp> ) in patients with <scp>L</scp> ynch <scp>S</scp> yndrome (hereditary nonpolyposis colorectal cancer syndrome)

Abstract

Patients with LS who develop UTUC present at younger ages and appear to be more likely to have bilateral UT disease over their lifetimes vs sporadic UTUC patients. Ureteroscopic laser ablation offers a good renal preservation rate with reasonable cancer control in patients willing to undergo endoscopic surveillance. Development of new bladder tumours is common.